Redirecting thromboxane A2 and prostacyclin biosyntheses from thrombotic to antithrombotic property by an Enzymelink

Ruan, D. T., Lu, R., & Ruan, K.-H. (2021). Redirecting Thromboxane A2 and Prostacyclin Biosyntheses from Thrombotic to Antithrombotic Property by an Enzymelink. Future Medicinal Chemistry, 13(9), 765–768. https://doi.org/10.4155/fmc-2020-0340
Authors:
Diana T Ruan
Renzhong Lu
Ke-He Ruan
Affiliated Authors:
Diana T Ruan
Columbia Affiliation:
Subjects:
Epoprostenol (MeSH)
Fibrinolytic Agents (MeSH)
Thrombosis (MeSH)
Thromboxane A2 (MeSH)
Author Keywords:
enzymelink
pgi2
txa2
antithrombosis
cyclooxygenase
prostacyclin
thromboxane a2
elink
Publication Type:
Article
Unique ID:
10.4155/fmc-2020-0340
PMID:
33759567
DOI:
10.4155/fmc-2020-0340
Journal:
Future Medicinal Chemistry
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record

Record Created:

Report an error in this record